Covid: The popular painkiller that could cut the length of hospitalisation from the virus

Covid booster ’enough to stop serious infection’ says expert

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

One of the effective solutions against facing difficulties from the respiratory disease seems to be getting jabbed as two doses of Pfizer or AstraZeneca vaccine offer up to 96 percent protection against hospitalisation, according to the Office for National Statistics. Now, researchers have identified a new way that could help lower the length of being in hospital.

A study published in the journal Lancet looked at the link between taking aspirin and Covid.

Aspirin is a common painkiller used for treating all sorts of aches and pains.

Most types are readily available in most pharmacies, shops and supermarkets.

The new trial compared taking aspirin to usual care in patients hospitalised with COVID-19.

Around 177 hospitals in the UK along with two hospitals located in Indonesia and two in Nepal took place in this study.

The sample group that took aspirin was given the standard care plus 150 micrograms (mg) of the painkiller a day.

Aspirin usually comes in the form of a 300 mg tablet with the recommended dose being one or two tablets every four to six hours, the NHS explains.

The trial was ongoing for five months between November 2020 and March 2021.

About 14,892 patients enrolled in the trial and were separated into two groups, the one taking aspirin and the other sticking to usual care.

The aspirin group was hospitalised for a “slightly” shorter time, with an average of eight days.

A higher proportion was discharged from the hospital alive within 28 days.

Taking aspirin was also linked to a lower risk of thrombotic events.

Thrombosis describes when blood clots block your blood vessels. This can lead to various problems including a heart attack.

Covid has been associated with higher rates of blood clots in people seriously ill from the virus.

However, the new research pointing to the potential benefits of aspirin needs to be taken with a pinch of salt.

The research team has also found there was no significant difference when it came to the need for mechanical ventilation and 17 percent of the aspirin sample group died within 28 days.

Aspirin was linked to an increase in major bleeding events as well.

This is because the painkiller is a blood-thinner, which can make you bleed more easily.

This may manifest as nosebleeds, bruising more easily, or bleeding taking longer to stop when you cut yourself, the NHS states.

The main finding of this new study was a “slight” boost of being discharged alive within 28 days and a possible decrease in the hospitalisation length.

 

Source: Read Full Article